Device type · LMH
Implant, Dermal, For Aesthetic Use
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
LMH
General & Plastic Surgery
Device class
Class III
FDA decisions since 2015
34
510(k), De Novo and PMA
Adverse event reports
2,054
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Implant, Dermal, For Aesthetic Use
- Product code
- LMH
- Device class
- Class III
- Review panel
- General & Plastic Surgery
- FDA record
- Classification database entry for LMH
Latest FDA decisions
The 8 newest of 34 since 2015.
P250016 · Decided Jul 9, 2026 · 387 days after receipt
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
P250021 · Decided Jun 12, 2026 · 351 days after receipt
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
- SKINVIVE by JUVEDERM®PMA supplement
P110033-S099 · Decided Jun 11, 2026 · 394 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
P250020 · Decided May 19, 2026 · 327 days after receipt
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
- RHA Redensity® Eye Lido; RHA Redensity® EyePMA supplement
P170002-S050 · Decided May 12, 2026 · 256 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
- RADIESSE® Injectable ImplantPMA supplement
P050052-S162 · Decided Mar 31, 2026 · 678 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
- Restylane® ContourPMA supplement
P140029-S054 · Decided Mar 20, 2026 · 239 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
- Restylane® Lyft with LidocainePMA supplement
P040024-S142 · Decided Nov 4, 2025 · 278 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
Reports received
2,054
Received Nov 1, 2025 to Nov 19, 2026. Includes 5 of another or unstated type.
Malfunction reports
6
0.3% of reports
Injury reports
2,040
99% of reports
Death reports
3
0.1% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 108 | 1 | 1 |
| Jan 24 | 1 | 133 | 0 | 0 |
| Feb 24 | 1 | 122 | 0 | 0 |
| Mar 24 | 0 | 151 | 0 | 0 |
| Apr 24 | 1 | 94 | 0 | 0 |
| May 24 | 1 | 129 | 0 | 0 |
| Jun 24 | 0 | 73 | 0 | 0 |
| Jul 24 | 0 | 109 | 0 | 0 |
| Aug 24 | 1 | 103 | 0 | 0 |
| Sep 24 | 0 | 115 | 0 | 0 |
| Oct 24 | 2 | 123 | 0 | 0 |
| Nov 24 | 0 | 123 | 0 | 0 |
| Dec 24 | 0 | 111 | 0 | 0 |
| Jan 25 | 0 | 113 | 0 | 0 |
| Feb 25 | 0 | 106 | 0 | 0 |
| Mar 25 | 0 | 156 | 0 | 0 |
| Apr 25 | 0 | 159 | 1 | 0 |
| May 25 | 1 | 150 | 0 | 0 |
| Jun 25 | 2 | 111 | 0 | 0 |
| Jul 25 | 0 | 169 | 0 | 0 |
| Aug 25 | 0 | 128 | 0 | 0 |
| Sep 25 | 1 | 181 | 0 | 0 |
| Oct 25 | 0 | 242 | 0 | 0 |
| Nov 25 | 0 | 145 | 0 | 0 |
| Dec 25 | 1 | 159 | 0 | 0 |
| Jan 26 | 0 | 112 | 0 | 0 |
| Feb 26 | 1 | 157 | 0 | 0 |
| Mar 26 | 1 | 149 | 0 | 0 |
| Apr 26 | 1 | 164 | 0 | 0 |
| May 26 | 0 | 142 | 2 | 0 |
| Jun 26 | 2 | 174 | 0 | 0 |
| Jul 26 | 0 | 261 | 0 | 0 |
| Aug 26 | 0 | 186 | 0 | 1 |
| Sep 26 | 0 | 231 | 0 | 3 |
| Oct 26 | 0 | 160 | 1 | 1 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem1,615
- Off-Label Use337
- Improper or Incorrect Procedure or Method313
- Migration20
- No Apparent Adverse Event19
- Insufficient Device Problem Information14
- Patient-Device Incompatibility13
- Use of Device Problem10
- Patient Device Interaction Problem6
- Biofilm coating in Device4
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Nodule457
- Inflammation333
- Obstruction/Occlusion325
- Subcutaneous Nodule309
- No Clinical Signs, Symptoms or Conditions150
- Granuloma126
- Swelling/ Edema122
- Abscess110
- Unspecified Infection110
- Hypersensitivity/Allergic reaction83
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Revanesse Versa, PN40081Terminated
Prollenium Medical Technologies Inc.
Z-1146-2020 · Started Nov 15, 2018
Reason given: Labeling error. The product is labeled with an 18 month expiration date, however the product is approved for 12 months.
Cause as FDA categorized it: Other
Z-2607-2016 · Started May 20, 2016 · Posted by FDA Aug 19, 2016
Reason given: Complaints reported of Radiesse (+) unable to be expelled from the syringe and/or needle.
Cause as FDA categorized it: Nonconforming Material/Component
Z-0366-2016 · Started Oct 26, 2015 · Posted by FDA Dec 3, 2015
Reason given: The expiration date encoded in the UDI barcode on the label on the product carton and the peelable patient identification label is incorrect.
Cause as FDA categorized it: Other
Orthovita, Inc., dBA Stryker Orthobiologics.
Z-1353-2015 · Started Feb 26, 2015 · Posted by FDA Mar 30, 2015
Reason given: Several shipments of Vitagel product (a surgical hemostat) required to be stored at 2 -8 degrees Celsius (C) were not delivered to customers within the validated delivery time.
Cause as FDA categorized it: Storage
Z-2135-2014 · Started Aug 7, 2013 · Posted by FDA Aug 8, 2014
Reason given: Manufacturer made a change in the production process that resulted in a change in final gel weight. RECALL EXPANDED 7/8/2014 Firm expanded their recall to include all lots of product.
Cause as FDA categorized it: Device Design
Z-0145-2012 · Started Aug 18, 2011 · Posted by FDA Nov 1, 2011
Reason given: There is a potential leakage of product that may occur with Merz Aesthetics 1.5cc syringes of Radiesse Dermal Filler. When using the syringe, Health Care Professionals should be alerted to the potential for product that my leak pass the plunger at the proximal end of the syring. The defect may result in infection...
Cause as FDA categorized it: Nonconforming Material/Component
Z-2221-2011 · Started Apr 6, 2011 · Posted by FDA May 19, 2011
Reason given: Merz Aesthetics, Inc. is recalling 1 lot (1034417) of Radiesse 1.3 cc Implant. The lot was supposed to be scrapped because it had failed to meet its Loss On Drying (LOD) specification. Unfortunately it had been marked as approved, released and shipped.
Cause as FDA categorized it: Employee error
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.